Loading company
Bright Minds Biosciences Inc.
DRUG · Nasdaq · ·
$49.67-3.8%Sep 29 close
- 1M
- -29.9%
- 6M
- -30.7%
- 1Y
- -14.3%
From the company’s own 6-K filing.
Bright Minds Biosciences Inc. has no earnings call transcript available.
The quote and the company description come from the 6-K Bright Minds Biosciences Inc. filed on May 20, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
DRUG · Nasdaq · ·
$49.67-3.8%Sep 29 close